NZ's Truescreen hits over 5-month high on Mexican regulatory nod
** Shares of Truscreen Group TRU.NZ jump as much as 3.9%
to NZ$0.027, their highest level since Sept 1, 2023
** The medical device co says national regulator of Mexico,
Cofepris, has approved co access to the public health sector
** Says approval allows co to expand its cervical cancer
screening, currently in the private health clinics to the wider
public health sector
** TRU stock up ~13% YTD as of last close
(Reporting by Echha Jain in Bengaluru)
((Echha.jain@thomsonreuters.com))
Recent news on Truscreen
See all newsBrief: Truscreen Group Says Tony Ho To Resume Role As Independent Non-Executive Chairman
New Zealand's TruScreen tumbles on discounted placement
Brief: Truscreen Group Says NZ Regco Has Approved A Trading Halt
Brief: Truscreen Announces Opening Of NZ$2.9 Million Capital Raise
Brief: Truscreen Group Sees FY26 Unaudited Loss